These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 26899852)

  • 1. Inflammasome as a New Therapeutic Target for Diabetic Complications.
    Volpe CM; Anjos PM; Nogueira-Machado JA
    Recent Pat Endocr Metab Immune Drug Discov; 2016; 10(1):56-62. PubMed ID: 26899852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic regulation of the NLRP3 inflammasome in chronic inflammatory diseases.
    Seok JK; Kang HC; Cho YY; Lee HS; Lee JY
    Arch Pharm Res; 2021 Jan; 44(1):16-35. PubMed ID: 33534121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome in Cardiovascular Disorders.
    Wang Z; Hu W; Lu C; Ma Z; Jiang S; Gu C; Acuña-Castroviejo D; Yang Y
    Arterioscler Thromb Vasc Biol; 2018 Dec; 38(12):2765-2779. PubMed ID: 30571177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NLRP3 Inflammasome: Checkpoint Connecting Innate and Adaptive Immunity in Autoimmune Diseases.
    Zhang Y; Yang W; Li W; Zhao Y
    Front Immunol; 2021; 12():732933. PubMed ID: 34707607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new research hot spot: The role of NLRP3 inflammasome activation, a key step in pyroptosis, in diabetes and diabetic complications.
    Yu ZW; Zhang J; Li X; Wang Y; Fu YH; Gao XY
    Life Sci; 2020 Jan; 240():117138. PubMed ID: 31809715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting NLRP3 inflammasome as a promising approach for treatment of diabetic nephropathy: Preclinical evidences with therapeutic approaches.
    Ram C; Jha AK; Ghosh A; Gairola S; Syed AM; Murty US; Naidu VGM; Sahu BD
    Eur J Pharmacol; 2020 Oct; 885():173503. PubMed ID: 32858047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NLRP3 inflammasome as a potential treatment in ischemic stroke concomitant with diabetes.
    Hong P; Gu RN; Li FX; Xiong XX; Liang WB; You ZJ; Zhang HF
    J Neuroinflammation; 2019 Jun; 16(1):121. PubMed ID: 31174550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammasome in Dendritic Cells Immunobiology: Implications to Diseases and Therapeutic Strategies.
    Ferreira I; Liberal J; Martins JD; Silva A; Neves BM; Cruz MT
    Curr Drug Targets; 2017; 18(9):1003-1018. PubMed ID: 27660056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular Models and Assays to Study NLRP3 Inflammasome Biology.
    Zito G; Buscetta M; Cimino M; Dino P; Bucchieri F; Cipollina C
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orchestration of NLRP3 Inflammasome Activation by Ion Fluxes.
    Gong T; Yang Y; Jin T; Jiang W; Zhou R
    Trends Immunol; 2018 May; 39(5):393-406. PubMed ID: 29452983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of NLRP3 Inflammasome by Phosphorylation.
    Song N; Li T
    Front Immunol; 2018; 9():2305. PubMed ID: 30349539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NLRP3 inflammasome in ischemic stroke: As possible therapeutic target.
    Alishahi M; Farzaneh M; Ghaedrahmati F; Nejabatdoust A; Sarkaki A; Khoshnam SE
    Int J Stroke; 2019 Aug; 14(6):574-591. PubMed ID: 30940045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NLRP3 Inflammasome as a Pharmacological Target.
    Marchetti C
    J Cardiovasc Pharmacol; 2019 Oct; 74(4):285-296. PubMed ID: 31335445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiting the NLRP3 Inflammasome Activation with MCC950 Ameliorates Diabetic Encephalopathy in db/db Mice.
    Zhai Y; Meng X; Ye T; Xie W; Sun G; Sun X
    Molecules; 2018 Feb; 23(3):. PubMed ID: 29495433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NLRP3 inflammasome activation is associated with proliferative diabetic retinopathy.
    Loukovaara S; Piippo N; Kinnunen K; Hytti M; Kaarniranta K; Kauppinen A
    Acta Ophthalmol; 2017 Dec; 95(8):803-808. PubMed ID: 28271611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research Progress on the Role of Inflammasomes in Kidney Disease.
    Chi K; Geng X; Liu C; Cai G; Hong Q
    Mediators Inflamm; 2020; 2020():8032797. PubMed ID: 32410864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin: an inflammasome silencer.
    Hasanzadeh S; Read MI; Bland AR; Majeed M; Jamialahmadi T; Sahebkar A
    Pharmacol Res; 2020 Sep; 159():104921. PubMed ID: 32464325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
    Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
    Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammasomes contributing to inflammation in arthritis.
    Spel L; Martinon F
    Immunol Rev; 2020 Mar; 294(1):48-62. PubMed ID: 31944344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NLRP3 Inflammasome in Acute Myocardial Infarction.
    Mauro AG; Bonaventura A; Mezzaroma E; Quader M; Toldo S
    J Cardiovasc Pharmacol; 2019 Sep; 74(3):175-187. PubMed ID: 31356555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.